Search

Search Constraints

You searched for: Author/Creator Ferrandina, Gabriella

Search Results

1. 2022-RA-1433-ESGO Reproductive outcomes after conservative treatment in malignant ovarian germ cell tumors (MOGCTs) patients: a MITO-9 study. (20th October 2022)

2. 2022-RA-201-ESGO Locally advanced cervical carcinoma patients treated with chemoradiation followed by radical surgery: clinical response and oncological outcomes according to histotype after propensity score analysis. (20th October 2022)

3. 227 Fertility-sparing treatment in advanced borderline ovarian tumors. an analysis from the mito14 study database. (4th December 2020)

4. A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups. (10th October 2019)

6. Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison. (February 2014)

7. Assessing the role of minimally invasive radical hysterectomy for early-stage cervical cancer. (August 2022)

8. Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? an international multicenter analysis. (September 2020)

9. Cervical cancer patterns of care in Italy: A radiation oncology survey of MITO and AIRO GYN groups. (May 2020)

10. Corrigendum to "Assessing the role of minimally invasive radical hysterectomy for early-stage cervical cancer" [Eur. J. Obstet. Gynecol. 275 (2022) 64–69]. (November 2022)